Cargando…
苯达莫司汀联合利妥昔单抗治疗复发滤泡性淋巴瘤的临床分析
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Editorial office of Chinese Journal of Hematology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9800227/ https://www.ncbi.nlm.nih.gov/pubmed/35968596 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2022.06.012 |
_version_ | 1784861248946438144 |
---|---|
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9800227 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Editorial office of Chinese Journal of Hematology |
record_format | MEDLINE/PubMed |
spelling | pubmed-98002272022-12-30 苯达莫司汀联合利妥昔单抗治疗复发滤泡性淋巴瘤的临床分析 Zhonghua Xue Ye Xue Za Zhi 短篇论著 Editorial office of Chinese Journal of Hematology 2022-06 /pmc/articles/PMC9800227/ /pubmed/35968596 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2022.06.012 Text en 2022年版权归中华医学会所有 https://creativecommons.org/licenses/by/3.0/This work is licensed under a Creative Commons Attribution 3.0 License. |
spellingShingle | 短篇论著 苯达莫司汀联合利妥昔单抗治疗复发滤泡性淋巴瘤的临床分析 |
title | 苯达莫司汀联合利妥昔单抗治疗复发滤泡性淋巴瘤的临床分析 |
title_full | 苯达莫司汀联合利妥昔单抗治疗复发滤泡性淋巴瘤的临床分析 |
title_fullStr | 苯达莫司汀联合利妥昔单抗治疗复发滤泡性淋巴瘤的临床分析 |
title_full_unstemmed | 苯达莫司汀联合利妥昔单抗治疗复发滤泡性淋巴瘤的临床分析 |
title_short | 苯达莫司汀联合利妥昔单抗治疗复发滤泡性淋巴瘤的临床分析 |
title_sort | 苯达莫司汀联合利妥昔单抗治疗复发滤泡性淋巴瘤的临床分析 |
topic | 短篇论著 |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9800227/ https://www.ncbi.nlm.nih.gov/pubmed/35968596 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2022.06.012 |
work_keys_str_mv | AT běndámòsītīngliánhélìtuǒxīdānkàngzhìliáofùfālǜpàoxìnglínbāliúdelínchuángfēnxī AT běndámòsītīngliánhélìtuǒxīdānkàngzhìliáofùfālǜpàoxìnglínbāliúdelínchuángfēnxī AT běndámòsītīngliánhélìtuǒxīdānkàngzhìliáofùfālǜpàoxìnglínbāliúdelínchuángfēnxī AT běndámòsītīngliánhélìtuǒxīdānkàngzhìliáofùfālǜpàoxìnglínbāliúdelínchuángfēnxī AT běndámòsītīngliánhélìtuǒxīdānkàngzhìliáofùfālǜpàoxìnglínbāliúdelínchuángfēnxī AT běndámòsītīngliánhélìtuǒxīdānkàngzhìliáofùfālǜpàoxìnglínbāliúdelínchuángfēnxī AT běndámòsītīngliánhélìtuǒxīdānkàngzhìliáofùfālǜpàoxìnglínbāliúdelínchuángfēnxī AT běndámòsītīngliánhélìtuǒxīdānkàngzhìliáofùfālǜpàoxìnglínbāliúdelínchuángfēnxī |